Mounjaro Weight Loss (Tirzepatide) Injections
– Weekly GLP-1 & GIP Receptor Agonist for Weight Management and Blood Sugar Control
Mounjaro Weight Loss (tirzepatide) is an FDA-approved, once-weekly prescription injection manufactured by Eli Lilly and Company to improve blood sugar (glycemic control) in adults and pediatric patients 10 years and older with type 2 diabetes. Because of its highly effective dual-action formula, it is also widely prescribed off-label (and approved under the sister brand name Zepbound) for chronic weight management.
Mounjaro (tirzepatide) represents a first-in-class medical advancement for individuals managing type 2 diabetes. It is the first authorized single-molecule medication that acts as a dual GIP and GLP-1 receptor agonist. By mimicking two naturally occurring gut hormones, Mounjaro takes a multi-pathway approach to metabolic health—significantly lowering HbA1c levels while naturally reducing appetite and promoting substantial weight loss when combined with diet and exercise.
Available in multiple dosage strengths, Mounjaro offers a convenient weekly dosing schedule and is supplied in easy-to-use injection pens. Patients using tirzepatide may experience improved glycemic control, reduced appetite, and support for long-term weight-loss goals as part of a comprehensive treatment plan that includes diet and exercise.
How Mounjaro Weight Loss Works
Mounjaro utilizes a dual-action approach to regulate your body’s glucose metabolism:
✔ Enhances Insulin Response: Signals the pancreas to release the optimal amount of insulin only when blood sugar levels rise.
✔ Suppresses Excess Glucagon: Prevents the liver from releasing stored, unnecessary sugars into your bloodstream.
✔ Delays Gastric Emptying: Slows down the rate at which food leaves the stomach, preventing post-meal spikes and keeping you feeling full for longer.
Key Benefits of Mounjaro Weight Loss
✔ Superior Blood Sugar Management: Clinical trials published demonstrate sustained, industry-leading reductions in HbA1c compared to traditional single-receptor treatments.
✔ Significant Weight Reduction: While approved for glycemic control, patients frequently experience clinically meaningful weight loss as a primary secondary benefit.
✔ Convenient Weekly Dosing: Administered just once a week, at any time of day, with or without meals.
Dosage and Availability
Mounjaro is available in single-dose prefilled autoinjector pens or multi-dose KwikPens. To minimize initial digestive side effects, treatment follows a doctor-supervised, gradual titration schedule:
Starting Dose: 2.5 mg injected subcutaneously once weekly for the first 4 weeks.
Maintenance Doses: 5 mg, 10 mg, and 15 mg weekly (escalating in 2.5 mg increments every 4 weeks as clinically required).
Injection Sites: Subcutaneous tissue of the abdomen, thigh, or upper arm (sites should be rotated each week).
Pack of 6 ( Available in 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg Strength )
Common Side Effects
Common Side Effects: Users may experience temporary nausea, diarrhea, decreased appetite, vomiting, constipation, or mild abdominal pain as the body adjusts.
Boxed Warning: Mounjaro causes thyroid C-cell tumors in rats. It is strictly contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Usage Constraints: Not intended for patients with type 1 diabetes or individuals with a history of pancreatitis. Mounjaro may also temporarily reduce the efficacy of oral contraceptives due to delayed stomach emptying.
Where to buy Mounjaro Weight Loss
Leafly Dispensary allows you to complete a digital medical questionnaire and text consultation with our licensed practitioners. If you qualify, we prescript and ship the medication directly to your door in temperature-controlled packaging.
Leave a Reply